DNA X INC

Insider Trading & Executive Data

SONM
NASDAQ
Technology
Communication Equipment

Start Free Trial

Get the full insider signal for SONM

10 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.

Trade-level insider transactions with filing links, transaction codes, and footnotes
Executive compensation trends by role with year-over-year comparisons
Institutional ownership shifts by quarter with top-holder concentration data
Form 144 and Form 8-K monitoring with AI analysis and CSV export tools

Insider Activity Summary

Insider Trades (1Y)
10
0 in last 30 days
Buy / Sell (1Y)
2/8
Acquisitions / Dispositions
Unique Insiders (1Y)
7
Active in past year
Insider Positions
9
Current holdings
Position Status
8/1
Active / Exited
Institutional Holders
8
Latest quarter
Board Members
3

Compensation & Governance

Avg Total Compensation
$661842.41
Latest year: 2024
Executives Covered
5
Comp records available
Form 8-K Events (1Y)
8
Personnel Changes (1Y)
6
Bonus Plan Events (1Y)
3
Organization Changes (1Y)
0
Board Appointments (1Y)
3
Board Departures (1Y)
1

Restricted Sales

Form 144 Filings (1Y)
0
Form 144 Insiders (1Y)
0
Planned Sale Shares (1Y)
0
Planned Sale Value (1Y)
$0.00
Price
$3.17
Market Cap
$5.0M
Volume
192
EPS
$-4.83
Revenue
$16.2M
Employees
131
About DNA X INC

Company Overview

Sonim Technologies is a niche provider of ruggedized enterprise 5G and connected solutions — handsets, smartphones, mobile hotspots/FWA devices, software (SonimWare), services and industrial accessories — sold primarily through major wireless carriers and distribution partners. The company exited low‑margin white‑label tablets in 2024, invested heavily in R&D for new rugged phones and hotspots, and experienced a steep revenue decline (2024 revenue $58.3M vs. $93.6M in 2023) and a material net loss driven by impairments, certification timing and manufacturing changes. Carrier concentration is high (wireless carriers ~75% of revenue; top three ~62–70%+), manufacturing is being re‑sited outside China, and liquidity has been managed by ATM sales, notes, receivables factoring and an announced asset sale and potential reverse merger. Revenue and margins are lumpy and tightly tied to carrier certifications, product launches and recoverability of capitalized certification/NRE costs.

Executive Compensation Practices

Given Sonim’s product‑ and certification‑driven model, executive pay is likely oriented toward incentives tied to carrier awards, successful device certifications/shipments, revenue and margin recovery, and key R&D milestones (e.g., XP Pro/thermal variants, H500/H700 hotspots). The technology/communication equipment sector norm — significant equity participation (options/RSUs), milestone‑based bonuses and long‑term incentives — is especially likely here because the company is conserving cash while needing to retain engineering and sales talent during a turnaround. Management disclosures show large swings in R&D and impairments that materially affect reported profitability, so cash bonuses tied to GAAP earnings may be replaced or supplemented by non‑GAAP or milestone measures (certification milestones, adjusted EBITDA or product revenue targets). Special situation items (asset sale, reverse merger, hostile takeover activity) also create a higher probability of retention, change‑in‑control or transaction bonus awards and potential accelerated vesting provisions.

Insider Trading Considerations

Material events for Sonim tend to be non‑continuous and event‑driven: carrier certifications/awards, product launch timing, impairment or recoverability judgments on capitalized NRE, financing/ATM issuances, and M&A/asset sale negotiations — each of which can create concentrated windows of material nonpublic information. Investors should monitor insider trades, option exercises and Form 4 filings around certification announcements, carrier rollouts and financing closings; insider sales concurrent with ATM or financing activity may reflect liquidity needs rather than negative operational signals. Regulatory constraints relevant here include Section 16 and Rule 10b5‑1 trading plans, carrier and FCC/NTIA device certification timing (which drives disclosure cadence), TAA/government procurement rules, and any contractual lockups or prepayment/pledge covenants in financing documents that can restrict or incentivize insider disposition.

Unlock Full Insider Trading Data
Get complete access to insider trades, executive compensation, institutional holdings, and AI-powered analysis for DNA X INC and thousands of other companies.
Individual insider trade details with transaction history
Executive compensation breakdown by position
Institutional holder analysis with quarterly comparisons
Insider holdings with temporal change tracking
Form 144 restricted sale filings with details
Form 8-K governance events and personnel changes
10b5-1 trading plan analysis
AI-powered insights and conversational analysis
Board of directors profiles and governance data
Advanced filtering, sorting, and CSV export
7-day free trial included
Cancel anytime